The Ebola patient in Dallas who received an experimental Chimerix Inc drug died Wednesday but infectiousdisease researchers keen for any new tool to fight the widening viral outbreak said it was premature to rule out the drugs potential to treat Ebola The Chimerix drug brincidofovir is one of several experimental therapies that are being deployed against Ebola on a limited basis in the absence of any approved Ebolaspecific drugs or vaccines Brincidofovir and the other drugs havent been tested in human studies against
  